Galderma Labs Drug Patent Portfolio

Galderma Labs owns 2 orange book drugs protected by 14 US patents Given below is the list of Galderma Labs's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8703820 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders 12 Mar, 2023 Expired
US8729127 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders 12 Mar, 2023 Expired
US9381179 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders 12 Mar, 2023 Expired
US9387187 Administration of 6[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders 12 Mar, 2023 Expired
US8445543 Combinations of adapalene and benzoyl peroxide for treating acne lesions 23 Dec, 2022 Expired
US8785420 Combination/association of adapalene and benzoyl peroxide for treating acne lesions 23 Dec, 2022 Expired
US8809305 Administration of adapalene and benzoyl peroxide for the long-term treatment of acne vulgaris 23 Dec, 2022 Expired
US8909305 Method and system for activating an application on a mobile device 23 Dec, 2022 Expired
US8936800 Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt 23 Dec, 2022 Expired
US9814690 Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt 23 Dec, 2022 Expired
US7700081 Foaming compositions for hair care 03 Jan, 2022 Expired
US7316810 Foaming composition for washing and treating hair and/or scalp based on an active principle 17 Jun, 2019 Expired
US8066975 Foaming composition for washing and treating hair and/or scalp based on an active principle 17 Jun, 2019 Expired
US8066976 Foaming compositions for hair care 17 Jun, 2019 Expired


Given below is the list of recent legal activities going on the following drug patents of Galderma Labs.

Activity Date Patent Number
Patent litigations
Maintenance Fee Reminder Mailed 04 Mar, 2024 US9387187
Maintenance Fee Reminder Mailed 26 Feb, 2024 US9381179
Expire Patent 01 Jan, 2024 US8066976
Expire Patent 01 Jan, 2024 US8066975
Maintenance Fee Reminder Mailed 17 Jul, 2023 US8066976
Maintenance Fee Reminder Mailed 17 Jul, 2023 US8066975
Expire Patent 23 May, 2022 US7700081
Payment of Maintenance Fee, 8th Year, Large Entity 11 May, 2022 US8909305
Payment of Maintenance Fee, 8th Year, Large Entity 09 Feb, 2022 US8809305 (Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 14 Jan, 2022 US8785420
Maintenance Fee Reminder Mailed 06 Dec, 2021 US7700081
Payment of Maintenance Fee, 4th Year, Large Entity 28 Apr, 2021 US9814690
Payment of Maintenance Fee, 8th Year, Large Entity 24 Sep, 2020 US8445543
Payment of Maintenance Fee, 4th Year, Large Entity 30 Dec, 2019 US9387187
Payment of Maintenance Fee, 4th Year, Large Entity 19 Dec, 2019 US9381179


Galderma Labs Drug Patents' Oppositions Filed in EPO

Galderma Labs drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Mar 05, 2014, by Generics [Uk] Limited. This opposition was filed on patent number EP07787478A. Click below to reveal the latest opposition data.


Application Filing Date Opposition Party Legal Status
Patent litigations
EP08708470A Mar, 2016 Generics (U.K.) Limited Revoked
EP07787478A Mar, 2014 Generics [UK] Limited Opposition rejected


Galderma Labs's Family Patents

Galderma Labs drugs have patent protection in a total of 29 countries. It's US patent count contributes only to 26.1% of its total global patent coverage. 7 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Galderma Labs Drug List

Given below is the complete list of Galderma Labs's drugs and the patents protecting them.


1. Clobex

Clobex is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7700081 Foaming compositions for hair care 03 Jan, 2022
(2 years ago)
Expired
US7316810 Foaming composition for washing and treating hair and/or scalp based on an active principle 17 Jun, 2019
(5 years ago)
Expired
US8066975 Foaming composition for washing and treating hair and/or scalp based on an active principle 17 Jun, 2019
(5 years ago)
Expired
US8066976 Foaming compositions for hair care 17 Jun, 2019
(5 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Clobex's drug page


2. Epiduo Forte

Epiduo Forte is protected by 10 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8703820 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders 12 Mar, 2023
(1 year, 6 months ago)
Expired
US8729127 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders 12 Mar, 2023
(1 year, 6 months ago)
Expired
US9381179 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders 12 Mar, 2023
(1 year, 6 months ago)
Expired
US9387187 Administration of 6[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders 12 Mar, 2023
(1 year, 6 months ago)
Expired
US8445543 Combinations of adapalene and benzoyl peroxide for treating acne lesions 23 Dec, 2022
(1 year, 9 months ago)
Expired
US8785420 Combination/association of adapalene and benzoyl peroxide for treating acne lesions 23 Dec, 2022
(1 year, 9 months ago)
Expired
US8809305 Administration of adapalene and benzoyl peroxide for the long-term treatment of acne vulgaris 23 Dec, 2022
(1 year, 9 months ago)
Expired
US8909305 Method and system for activating an application on a mobile device 23 Dec, 2022
(1 year, 9 months ago)
Expired
US8936800 Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt 23 Dec, 2022
(1 year, 9 months ago)
Expired
US9814690 Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt 23 Dec, 2022
(1 year, 9 months ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Epiduo Forte's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List